Precise Biometrics (PREC) Q3 2025 earnings summary

Executive summary

• Net sales for Q3 2025 were SEK 20.0 million, down 12.3% year-over-year; EBITDA was positive at SEK 4.4 million, but EBIT was negative at SEK -0.6 million.

• For January–September 2025, net sales reached SEK 60.8 million, a 6.6% decrease year-over-year; EBITDA was SEK 2.1 million, and EBIT was SEK -13.4 million.

• Annual Recurring Revenue (ARR) remained stable at SEK 18.4 million.

• The company maintained a strong position in biometrics, with growing demand for anti-spoofing and liveness solutions, and continued migration of customers to cloud-based offerings.

Financial highlights

• Q3 net sales: SEK 20.0 million (Q3 2024: SEK 22.8 million); EBITDA: SEK 4.4 million (Q3 2024: SEK 6.8 million); EBIT: SEK -0.6 million (Q3 2024: SEK 1.2 million).

• Interim period net sales: SEK 60.8 million (2024: SEK 65.1 million); EBITDA: SEK 2.1 million (2024: SEK 9.9 million); EBIT: SEK -13.4 million (2024: SEK -7.3 million).

• Gross margin for Q3: 75.8% (Q3 2024: 74.3%); interim period: 73.8% (2024: 72.7%).

• Cash flow from operating activities for Q3: SEK 1.7 million (Q3 2024: SEK 3.3 million); cash and cash equivalents at period end: SEK 31.3 million.

• Earnings per share for Q3: SEK -0.01 (Q3 2024: SEK 0.02); for the interim period: SEK -0.17 (2024: SEK -0.09).

Outlook and guidance

• Management expects continued growth in demand for biometric and cybersecurity solutions, especially in mobile, government, and physical access markets.

• Migration to cloud-based solutions is expected to drive long-term scalability and profitability, despite short-term churn.

• The company anticipates positive effects on earnings from increased efficiency and optimized supplier agreements.